Preliminary Study IDs Genetic Biomarkers Linking Erythropoietin to Cancer Growth | GenomeWeb
CHICAGO (GenomeWeb News) — An increasing body of evidence is showing that erythropoietin, the widely used hematopoietic drug used to counter the anemia caused by most chemotherapies, may also encourage cancer cells themselves to grow in certain malignancies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.